New User? Sign Up | Sign In

Insider Trading - Black Diamond Therapeutics Inc. (BDTX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
BDTX Insider Trading Transactions for Black Diamond Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-02-03
Purchase
2020-02-05
6:02 pm
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
894,736 $19 $16,999,984 1,206,603
(Indirect
Direct)
View
2020-02-03
Purchase
2020-02-05
5:59 pm
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
894,736 $19 $16,999,984 1,206,603
(Indirect)
View
2020-02-03
Purchase
2020-02-05
5:58 pm
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
1,000,000 $19 $19,000,000 353,814
(Indirect)
View
2020-02-03
Purchase
2020-02-05
5:55 pm
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
3,000 $19 $57,000 3,000
(Direct)
View
2020-02-03
Purchase
2020-02-05
5:55 pm
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
800,000 $19 $15,200,000 3,448,757
(Indirect)
View
2020-02-03
Purchase
2020-02-03
1:25 pm
Black Diamond Therapeutics Inc. BDTX Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
10% Owner
400,000 $19 $7,600,000 778,790
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-02-03
Conversion
2020-02-05
6:06 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
568,185 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:06 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
1,713,541 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
4,973,787 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
380,817 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,277,111 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
653,412 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
150,085 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
503,327 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
454,548 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
104,407 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
350,141 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
810,522 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
15,000,000 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,148,474 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
3,851,526 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,970,572 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
452,630 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,517,940 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,370,833 $0 1,206,603
(Direct)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
314,873 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
1,055,960 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
6:02 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Versant Venture Capital VI L.P.
Versant Voyageurs I Parallel L.P.
Versant Voyageurs I L.P.
Versant Vantage I L.P.
10% Owner
2,444,382 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
4,973,787 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
380,817 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,277,111 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
653,412 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
150,085 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
503,327 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
810,522 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
454,548 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
104,407 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
350,141 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
15,000,000 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,148,474 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
3,851,526 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,970,572 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
452,630 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,517,940 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
2,444,382 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,370,833 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
314,873 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:59 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Bolzon Bradley J PhD
Director
1,055,960 $0 1,206,603
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
956,723 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
163,353 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
186,749 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
181,783 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
70,770 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
30,526 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
2,885,295 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
492,643 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
563,204 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
548,224 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
213,429 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:58 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Shah Rajeev M.
Director
92,063 $0 353,814
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
242,904 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
23,090 $0 0
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
4,354 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
732,560 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
69,636 $0 0
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:57 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
13,136 $0 0
(Direct)
View
2020-02-03
Conversion
2020-02-05
5:56 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Menzel Garry E
Director
51,825 $0 0
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:56 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Menzel Garry E
Director
156,297 $0 0
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
2,176,957 $0 3,448,757
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
471,800 $0 3,448,757
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
6,565,290 $0 3,448,757
(Indirect)
View
2020-02-03
Conversion
2020-02-05
5:55 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Behbahani Ali
Director
1,422,862 $0 3,448,757
(Indirect)
View
2020-02-03
Conversion
2020-02-03
1:25 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
10% Owner
378,790 $0 778,790
(Indirect)
View
2020-02-03
Conversion
2020-02-03
1:25 pm
N/A
N/A
Black Diamond Therapeutics Inc. BDTX Flynn James E
Deerfield Mgmt L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
DEERFIELD PARTNERS L.P.
10% Owner
1,142,361 $0 778,790
(Indirect)
View
2020-01-29
Option Award
2020-01-31
4:55 pm
N/A
2030-01-29
Black Diamond Therapeutics Inc. BDTX Leggett Thomas
CFO
55,540 $19 55,540
(Direct)
View
2020-01-29
Option Award
2020-01-31
4:52 pm
N/A
2030-01-29
Black Diamond Therapeutics Inc. BDTX Roberts Christopher D.
Chief Scientific Officer
54,711 $19 54,711
(Direct)
View
2020-01-29
Option Award
2020-01-31
4:51 pm
N/A
2030-01-29
Black Diamond Therapeutics Inc. BDTX Epstein David M.
Director
278,532 $19 278,532
(Direct)
View
2020-01-29
Option Award
2020-01-31
4:50 pm
N/A
2030-01-29
Black Diamond Therapeutics Inc. BDTX Hatzis-Schoch Brent
See Remarks
78,751 $19 78,751
(Direct)
View